Related Experiment Video
Updated: Oct 5, 2025

04:16
Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
637
Can recombinant milk proteins replace those produced by animals?
1Dairy Science & Technology, Food Quality and Design Group, Wageningen University & Research, 6708WG Wageningen, The Netherlands.
Current Opinion in Biotechnology
|February 1, 2022
Summary
Recombinant technology offers a sustainable alternative to traditional dairy production, addressing animal welfare concerns. Future research will focus on cost-effective and eco-friendly methods for producing milk proteins and casein micelles.
Area of Science:
- Biotechnology
- Food Science
- Sustainable Agriculture
Background:
- Animal proteins, especially dairy, face sustainability and animal welfare challenges.
- Recombinant synthesis of milk proteins is a growing area of interest.
- Current expression systems can produce milk proteins, but yield and purity are key for economic viability.
Purpose of the Study:
- To review the feasibility of producing recombinant dairy products.
- To highlight the importance of achieving high yield and purity.
- To emphasize the need for constructing casein micelle structures.
Main Methods:
- Review of current state-of-the-art in recombinant milk protein synthesis.
- Analysis of expression systems for protein production.
- Assessment of structural assembly into casein micelles.
Main Results:
- Recombinant synthesis of milk proteins is technically feasible across various systems.
- High yield and purity are critical for economic viability.
- Construction of casein micelles alongside protein synthesis is necessary.
Conclusions:
- The technical steps for producing recombinant dairy products are established.
- Economic feasibility and environmental friendliness require further investigation.
- The future of dairy production may involve recombinant alternatives.
More Related Videos
Related Concept Videos
Recombinant DNA
97.1K
Overview
97.1K
The Central Dogma
28.7K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
28.7K
Transgenic Organisms
31.8K
Overview
31.8K
Transgenic Plants
7.6K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
7.6K
Hybridoma Technology
15.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.6K

